The World Health Organization classification of pancreaticobiliary cytopathology stratifies risk of malignancy and outcome for endoscopic ultrasound-guided fine-needle aspiration of the pancreas.
Shu Kwun LuiImani HargettZaynab PharaaMariela AvilesStephany BotelhoDominique L FelicianoVeronica KimKeith SigelMisha ArmstrongChristina E WilsonPari ShahKevin SoaresCarlie S SigelPublished in: Cancer cytopathology (2023)
Cystic versus solid lesion type can dramatically affect AROM, particularly for nondiagnostic (I), benign (II), atypical (III), and WHO V categories. WHO IV conveys a similarly low AROM for cystic and solid types. Both classifications stratify the probability of overall survival, including the newly introduced categories WHO IV and WHO V.